Non-GAAP full-year EPS -- $2.84, up 81% year over year; GAAP full-year EPS was $3.70. Operating expenses -- Fourth quarter GAAP: $744 million; fourth quarter non-GAAP: $517 million; first quarter ...

Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter and Full Year 2025 Financial Results. [Operator Instructions] Please note, this event is being ...

Q4 2025 Earnings Call February 27, 2026 3:30 AM ESTCompany ParticipantsDaniel ThomsonPhilippe Guillemot - Group Chairman ...

Every SLTDA (Sri Lanka Tourism Development Authority) press release now leads with the same headline: India is Sri Lanka’s “star market.” The numbers seem to prove it, 531,511 Indian arrivals in 2025, ...

Wall Street is in a downward pattern after days of volatility. Markets have been buffeted by developments in the conflict in ...